Tag: Niarmedic Plus

NEARMEDIC – Russian pharmaceutical, biotechnology and medical company founded in 1989 at the Gamaleya Research Institute for Epidemiology and Microbiology of the Russian Academy of Medical Sciences.
The NEARMEDIC pharmaceutical business is based on the successful R&D results of a new class of antiviral biotechnology – a mucosal surface acting inducer of interferon called Kagocel®, that is not absorbed from gastrointestinal tract so does not enter internal fluids of the body, making it non-toxic and safe. Kagocel® has a unique mechanism of action and pharmacokinetics due to it polymeric structure based on active molecules covalently linked to cellulose. The high efficacy of Kagocel® has been proved for treatment and prevention of influenza and ARVI in adults and children, as well as for treatment of herpes infection (including recurrent genital herpes). Kagocel® is registered in Russia, Ukraine and Byelorussia. Kagocel® has been listed as non-prescription OTC-drug in Russia since 2005. In 2009, the drug was included by the Russian MOH and Social Development into its provisional guidelines for “Treatment and prevention of pandemic influenza virus A(H1N1) infection in adults” and into the Approved List of essential and the most important drugs within the system of state procurement.

NEARMEDIC also participated with BioPHARMAHOLDING in the development of an innovative collagenic implant material COLLOST® (native unreconstructed bovine collagen with fully preserved fibrous structure) applicable and broadly used in different medical specialities. Clinical trials on use of COLLOST® (membranes, powder and gel) in the treatment of slow-healing wounds (bedsores, trophic ulcers, diabetic foot) proved its remarkable efficacy. COLLOST® 7% and 15% gels are widely used in cosmetology and aesthetic medicine for treatment of atrophic scars, stretch marks, wrinkles, contour face plasty. NEARMEDIC is the official exclusive distributor of COLLOST®.products manufactured by BioPHARMAHOLDING.

In 1996 NEARMEDIC entered the private medical and clinical laboratory services business. At present, the medical and clinical laboratory services are represented by a chain of NEARMEDIC clinics in Moscow (one general multi-purpose clinic, two specialized clinics, two analysis collection points and an at-home analysis collection service). NEARMEDIC centralized clinical laboratory performs over a thousand different types of analyses (including unique and rare laboratory tests). The high quality of medical services provided by NEARMEDIC is ensured by the unified quality standards and equipping, by personal approach to each patient, by using innovative, precise, timely, quick and adequate diagnostics, and by strict follow-up with treatment. The basis of the demand of NEARMEDIC medical and laboratory services is the high professional level of the medical personnel and strict observance of all requirements for the provision of a high quality service to a patient.

In the pharmaceutical portfolio of NEARMEDIC, there are unique domestic products: COLLOST® and antiviral drug Kagocel® as well as potential products in the development pipeline. Kagocel® is included by the Russian Ministry of Health and Social Development of the Russian Federation into the provisional guidelines for “Treatment and prevention of pandemic influenza virus A(H1N1) infection in adults”, and inserted in the List of essential and the most important drugs approved by the Order of the Chairman of the Government of the Russian Federation and included in the system of state procurement.

The clinical and laboratory medical business of NEARMEDIC comprises of a chain of medical centers, plus a home-visits service and a centralized clinical laboratory.
NEARMEDIC clinics, besides traditionally having a focus on the clinical diagnosis and cure of urogenital infections, immunity disorders and their consequences (gynecology, urology, dermatovenereology), now also provide a complete medical service in laboratory, clinical, functional and instrumental diagnostics, treatment (including in-patient treatment) and prevention of diseases in different medical specialities including therapy, pediatrics, vaccinology, cardiology, gastroenterology, endocrinology, proctology, traumatology and orthopedics, surgery, ophthalmology, otorhinolaryngology, dentistry, cosmetology and aesthetic medicine. The Centralized Clinical Laboratory NEARMEDIC runs modern automated laboratory equipment and is able to carry out more than a thousand types of studies (including unique and rare laboratory tests).

The long and expensive process to enter the international market

Nikolai Yemelianov - Niarmedic Plus
What is the difference between the native antiviral drugs and imported ones and what is necessary for their entry into foreign markets, described the head of the Department of medical research and inf...